Adjust Font Increase Font Decrease Font
  • Email
  • Print

Infographics

 

2/2/2011
Total biopharmaceutical company R&D, PhRMA member R&D, and NIH operating budget: 1995-2009
2/2/2011
The average cost to develop one new drug increased more than 60% from 2000 to 2005.
2/2/2011
During the last decade clinical trial designs and procedures have become much more complex.
2/2/2011
New pharmaceutical medicines face competition after a relatively short period on the market.
2/2/2011
On average, brand drugs face generic competition after 11.5 years, but generic companies can challenge patents as soon as four years after a brand enters the market.
2/2/2011
By 1995, nearly all first-class medicines being approved already had potential competitors in Phase II clinical testing.